✦ LIBER ✦

Current controversies in the treatment of hypertension

✍ Scribed by Alasdair Breckenridge

Book ID: 117015002
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 323 KB
Volume: 84
Category: Article
ISSN: 1555-7162
DOI: 10.1016/s0002-9343(88)91041-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current controversies in the treatment o

Current controversies in the treatment of hypertension

✍ Alasdair Breckenridge 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Introduction: Controversies in the Treat

Introduction: Controversies in the Treatment of Hypertension

✍ J.I.S. Robertson; W.H. Birkenhäger 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 38 KB

Varicocele: Current controversies in tre

Varicocele: Current controversies in treatment

✍ Wai-Tat NG 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB

Controversies in hypertension

✍ Norman M Kaplan; Lionel H Opie 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 231 KB

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 1 views

## Abstract The original article to which this Erratum refers was published in the September, 2004 issue of __Movement__ Disorders (2004) 19 (9) 997–1005.

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: Current controversies

✍ C. Warren Olanow; Yves Agid; Yoshi Mizuno; Alberto Albanese; U. Bonucelli; Phili 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Levodopa is the most effective symptomatic agent in the treatment of Parkinson's disease (PD) and the “gold standard” against which new agents must be compared. However, there remain two areas of controversy: (1) whether levodopa is toxic, and (2) whether levodopa directly causes motor